UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Brown Shipley& Co Ltd

Brown Shipley& Co Ltd trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,948 shares of the healthcare conglomerate’s stock after selling 1,869 shares during the period. UnitedHealth Group comprises about 3.4% of Brown Shipley& Co Ltd’s holdings, making the stock its 11th biggest position. Brown Shipley& Co Ltd’s holdings in UnitedHealth Group were worth $7,612,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Gateway Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 34.9% in the second quarter. Gateway Wealth Partners LLC now owns 1,211 shares of the healthcare conglomerate’s stock worth $617,000 after acquiring an additional 313 shares during the last quarter. Quarry LP lifted its holdings in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. Invst LLC grew its holdings in shares of UnitedHealth Group by 20.0% during the second quarter. Invst LLC now owns 1,510 shares of the healthcare conglomerate’s stock worth $747,000 after buying an additional 252 shares in the last quarter. Covington Investment Advisors Inc. lifted its stake in shares of UnitedHealth Group by 2.5% during the second quarter. Covington Investment Advisors Inc. now owns 25,602 shares of the healthcare conglomerate’s stock valued at $13,038,000 after buying an additional 627 shares during the period. Finally, Second Line Capital LLC grew its position in shares of UnitedHealth Group by 9.1% in the second quarter. Second Line Capital LLC now owns 4,798 shares of the healthcare conglomerate’s stock valued at $2,444,000 after purchasing an additional 402 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.2 %

Shares of NYSE:UNH opened at $581.85 on Monday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a fifty day simple moving average of $579.40 and a 200 day simple moving average of $524.39. The firm has a market cap of $537.29 billion, a PE ratio of 35.57, a price-to-earnings-growth ratio of 1.60 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period last year, the business posted $6.14 earnings per share. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.44%. UnitedHealth Group’s payout ratio is currently 51.34%.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on UNH shares. HSBC increased their price target on shares of UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Monday, September 16th. Truist Financial lifted their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Barclays lifted their price target on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, Wells Fargo & Company lifted their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.